[6] Cho K H, et al. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70...
HIVCardiovascular diseaseDyslipidemiaEvolocumabPCSK9 inhibitorsStatin intolerancedoi:10.1016/j.ijcard.2024.132953Francisco Akira Malta CardozoInstituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, BrazilMarcos Pita Lottenberg...
Lale Tokgozoglu教授表示:“近年来学界对于降低LDL-C的关注太高,让我们没有理由不促进患者LDL-C达标!(We have no excuse to get LDL cholesterol goals)”。那么Lale Tokgozoglu教授都介绍了哪些治疗方法,临床医生应该如何选择呢? 药物1 贝派地酸(Bempe...
These goals aim to address the social, economic, and environmental challenges facing the world and to achieve sustainable development by 2030. The 17 Sustainable Development Goals are: 1. No Poverty: End poverty in all its forms everywhere. 2. Zero Hunger: End hunger, achieve food security, ...
Because LDLf goals are considered, in the settings we study -- Reactive Modules games and iterated Boolean games with goals over finite traces -- players' goals can be defined to be regular properties while achieved in a finite, but arbitrarily large, trace. In particular, using alternating ...
Recent trial supports lower LDL targets (<75 mg/dL) using high dose atorvastatin. Non-cardiac death rate, however, raises question of whether these goals should be achieved by other means.
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary13,846,597,258visits served TheFreeDictionary Google ? Keyboard Word / Article Starts with Ends with Text EnglishEspañolDeutschFrançaisItalianoالعربية中文简体PolskiPortuguêsNederlandsNorskΕλληνικήРусский...
LIVALO is a statin proven to lower LDL (bad) cholesterol Wherever you are in your cholesterol management journey, see how LIVALO may be able to help you reach your goals. Could LIVALO be the right statin for you? SEE HOW LIVALO WORKS LDL=low-density lipoprotein. Meet the Cholesterol...
When we focused the analysis on patients registered after 2005, we clearly found that most heFH patients in this French study did not achieve their recommend LDL-C goals, based on the recent European recommendations [3]. The improvement in the number of treated patients over time, associated ...
- Lerodalcibep is a novel, adnectin-based, small protein-binding, third-generation PCSK9 inhibitor - Only once-monthly, single, self-administered PCSK9i; no refrigeration required at home or in travel - Patient-friendly features designed to enhance adherence to reach and maintain LDL-C goals ...